Lambda Therapeutics partners with Medidata for greater clinical trial efficiency

Lambda and Medidata have partnered to automate and consolidate data management processes for improved clinical trial efficiency. The partnership between Lambda and Medidata, allows both companies to offer clients a single unified platform optimising workflows, mitigating risks, securing data, and cutting costs. 

India-based Lambda Therapeutics provides diverse clinical trials solutions including Phase 2 to 4 late-phase clinical efficiency and safety patient-based trials, early phase development, and data management, among others. 

The company will implement Medidata’s cloud-based clinical solutions Rave EDC, Rave RTSM, and Rave Imaging. Rave’s imaging intelligent workflows simplify the collection of images and data and can also conduct edit checks and de-identification during the image uploading process. After uploading the images, the system automates the distribution and review process, as per the protocol design. The approach simplifies workflows and improves efficiencies, minimising the burden of image management. 

Combining Rave Imaging with EDC, allows for the collection of critical data to help manage clinical trials bringing the two data collection environments together for a unified data platform saving time, resources and costs. Rave RTSM, is built on Rave EDC, without double data entry and with reduced reconciliation speeding up study start-up and close-out.